Sanofi India Limited
SANOFI.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$67.87B
Close$
Share Statistics
| Market cap | $67.87 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $123.00 (4.18%) |
| Earnings per Share | $141.85 |
| Beta | 0.2 |
| Outstanding Shares | 23,028,130 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 20.95 |
|---|---|
| PEG | 104 |
| Price to Sales | 3.76 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$39.59
Average shareholder expectationRevenue Estimate
$4.43 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$49.30
Average shareholder expectationRevenue Estimate
$5.23 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sanofi India Limited
1,097 employees
CEO: Deepak Arora Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosi...